Corleen M. Roche
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
-
Start not stated–2025-08-05
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CG Oncology, Inc. (CGON) | Prior Chief Financial Officer Robert Lapetina (Prior Interim Principal Financial and Accounting Officer) | $288,890 | $2,322,299 |
| 2024 | CG Oncology, Inc. (CGON) | Chief Financial Officer | $446,357 | $9,845,800 |
| 2023 | CG Oncology, Inc. (CGON) | Chief Financial Officer | — | — |
| 2021 | Immunome Inc. (IMNM) | Chief Financial Officer | $282,051 | $3,096,344 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.